Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
42.89
-1.22 (-2.77%)
Mar 19, 2026, 3:00 PM CST
SHA:600211 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,327 | 1,648 | 1,860 | 1,140 | 764.41 |
Trading Asset Securities | 1,123 | 976.62 | 515.34 | 792.49 | 537.87 |
Cash & Short-Term Investments | 3,450 | 2,625 | 2,375 | 1,932 | 1,302 |
Cash Growth | 31.44% | 10.51% | 22.92% | 48.38% | 66.22% |
Accounts Receivable | 917.49 | 732.82 | 856.71 | 625.68 | 632.32 |
Other Receivables | 17.44 | 11.85 | 11.82 | 12.63 | 12.83 |
Receivables | 934.93 | 744.67 | 868.52 | 638.31 | 645.15 |
Inventory | 181.27 | 134.19 | 111.43 | 99.95 | 137.32 |
Prepaid Expenses | - | 0.31 | 0.01 | 1.5 | - |
Other Current Assets | 70.96 | 65.91 | 47.77 | 40.04 | 97.16 |
Total Current Assets | 4,637 | 3,570 | 3,403 | 2,712 | 2,182 |
Property, Plant & Equipment | 655.35 | 669.85 | 600.33 | 551.38 | 764.54 |
Long-Term Investments | 425.5 | 132.94 | 116.62 | 129.75 | 130.25 |
Goodwill | 84.01 | 8.88 | 8.88 | 8.88 | 8.88 |
Other Intangible Assets | 300.78 | 184.09 | 202.46 | 416.48 | 411.66 |
Long-Term Deferred Tax Assets | 132.52 | 151.05 | 115.48 | 71.34 | 67.16 |
Long-Term Deferred Charges | 5.62 | 2.63 | 1.93 | 2.79 | 47.69 |
Other Long-Term Assets | 26.3 | 27.99 | 138.79 | 206.96 | 190.57 |
Total Assets | 6,267 | 4,747 | 4,587 | 4,100 | 3,803 |
Accounts Payable | 39.16 | 13.5 | 5.51 | 14.37 | 13.22 |
Accrued Expenses | 41.11 | 377.65 | 530.39 | 412.7 | 398.67 |
Short-Term Debt | 800.27 | 272.17 | 499.99 | 486.1 | 534.66 |
Current Portion of Long-Term Debt | 0.85 | - | - | - | - |
Current Portion of Leases | - | 0.92 | 0.88 | 1 | 2.13 |
Current Income Taxes Payable | 85.82 | 25.5 | 45.31 | 27.13 | 22.13 |
Current Unearned Revenue | 2.95 | 4.91 | 9.84 | 5.34 | 3.29 |
Other Current Liabilities | 669.96 | 71.92 | 92.56 | 79.56 | 135.56 |
Total Current Liabilities | 1,640 | 766.57 | 1,184 | 1,026 | 1,110 |
Long-Term Leases | 0.15 | 0.3 | 1.13 | 1.14 | 1.86 |
Long-Term Unearned Revenue | 28.11 | 27.36 | 25.85 | 27.53 | 30.5 |
Long-Term Deferred Tax Liabilities | 25.46 | 1 | 2.29 | 14.01 | 15.61 |
Other Long-Term Liabilities | 436.06 | - | - | - | - |
Total Liabilities | 2,130 | 795.23 | 1,214 | 1,069 | 1,158 |
Common Stock | 322.32 | 322.32 | 247.94 | 247.94 | 247.94 |
Additional Paid-In Capital | 752.2 | 1,188 | 1,263 | 1,266 | 1,265 |
Retained Earnings | 2,664 | 2,330 | 1,773 | 1,455 | 1,169 |
Comprehensive Income & Other | 59.51 | 77.57 | 61.21 | 42.98 | -51.42 |
Total Common Equity | 3,798 | 3,918 | 3,345 | 3,012 | 2,630 |
Minority Interest | 339.05 | 34.29 | 29.03 | 19.03 | 14.66 |
Shareholders' Equity | 4,137 | 3,952 | 3,374 | 3,031 | 2,645 |
Total Liabilities & Equity | 6,267 | 4,747 | 4,587 | 4,100 | 3,803 |
Total Debt | 801.27 | 273.39 | 501.99 | 488.25 | 538.65 |
Net Cash (Debt) | 2,649 | 2,351 | 1,873 | 1,444 | 763.63 |
Net Cash Growth | 12.65% | 25.54% | 29.71% | 89.11% | -1.22% |
Net Cash Per Share | 8.22 | 7.29 | 5.80 | 4.48 | 2.36 |
Filing Date Shares Outstanding | 322.59 | 322.32 | 322.32 | 322.32 | 322.32 |
Total Common Shares Outstanding | 322.59 | 322.32 | 322.32 | 322.32 | 322.32 |
Working Capital | 2,997 | 2,803 | 2,218 | 1,686 | 1,072 |
Book Value Per Share | 11.77 | 12.16 | 10.38 | 9.34 | 8.16 |
Tangible Book Value | 3,414 | 3,725 | 3,133 | 2,586 | 2,210 |
Tangible Book Value Per Share | 10.58 | 11.56 | 9.72 | 8.02 | 6.86 |
Buildings | - | 580.07 | 462.4 | 389.99 | 439.89 |
Machinery | - | 447.84 | 446.34 | 139.22 | 159.08 |
Construction In Progress | - | 65.06 | 60.71 | 153.6 | 272.13 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.